ArticleBiomarker insights2025

CXCL10 (IP-10) and anti-ZnT8 autoantibodies: Exploratory indicators of risk in pancreatic transplant rejection.

Mikk Jäätma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.